Oslo University Hospital, Rikshospitalet, is one of the four main campuses of Oslo University Hospital in Oslo, Norway. It was an independent hospital, Rigshospitalet, later spelled Rikshospitalet, from 1826 to 2009, when it merged with other university hospitals in Oslo.
Rikshospitalet–Radiumhospitalet Hospital Trust was created in 2005 when Rikshospitalet merged with the Norwegian Radium Hospital. The trust belongs to the Southern and Eastern Norway Regional Health Authority.
Jon Sudbø is a Norwegian dentist, physician, and former medical researcher, who was exposed as a scientific fraudster in 2006. Over a period of several years, he fabricated results in the field of oncology which he published in leading medical journals. The article that led to his downfall, which was published in The Lancet, was based on 900 patients Sudbø had fabricated entirely. The editor of The Lancet described this as the biggest scientific fraud conducted by a single researcher ever.
A regional health authority is a state-owned enterprise responsible for specialist healthcare in one of four regions of Norway. Responsibilities of the RHFs include patient treatment, education of medical staff, research and training of patients and relatives. Areas covered by the authorities are hospitals, psychiatry, ambulance service, operation of pharmacies at the hospitals, emergency telephone number and laboratories. The actual performance is done by subsidiary health trusts (HF) that usually consist of one or more hospitals, with associate responsibilities. The authorities are subordinate to the Norwegian Ministry of Health and Care Services.
Southern and Eastern Norway Pharmaceutical Trust is a health trust owned by Southern and Eastern Norway Regional Health Authority that operates nineteen hospital pharmacies. The pharmacies are part of the Ditt Apotek chain and use Norsk Medisinaldepot as wholesaler.
Southern Norway Regional Health Authority was a regional health authority that covered the counties of Aust-Agder, Buskerud, Telemark, Vest-Agder and Vestfold in Norway, as well as the national hospitals in Oslo. The authority was founded on January 1, 2002, but merged with the Eastern Norway Regional Health Authority to form the new Southern and Eastern Norway Regional Health Authority on June 1, 2007.
Karl Ludvig "Kalle" Reichelt was a Norwegian medical researcher. He was best known for his research on the opioid peptides in casein and gluten. He also did important work on cancer.
PubGene AS is a bioinformatics company located in Oslo, Norway and is the daughter company of PubGene Inc.
The Ullevål Hageby Line is a light rail section of the Oslo Tramway. It runs from Stortorvet in the city center of Oslo, Norway to Rikshospitalet. It passes through the areas of St. Hanshaugen, Ullevål Hageby and Blindern before reaching Gaustad. It serves major institutions such as Oslo University College, Bislett Stadion, Ullevål University Hospital, the University of Oslo and Rikshospitalet. The line is served by route 17 and 18 by Oslo Sporvognsdrift using SL95 trams, while the tracks are owned by Kollektivtransportproduksjon.
Hans Ludvig Carl Huitfeldt was a Norwegian physician.
Oslo University Hospital is a university hospital in Oslo, Norway. With over 24,000 employees it is the largest hospital organization in Europe. It is affiliated with the Faculty of Medicine of the University of Oslo and is one of the largest medical research institutions in Europe.
Severin Andreas Heyerdahl was a Norwegian physician, radiologist and hospital director. He was a pioneer in the use of radiology and radiation therapy in Norway.
Ellen Gleditsch was a Norwegian radiochemist and Norway's second female professor. Starting her career as an assistant to Marie Curie, she became a pioneer in radiochemistry, establishing the half-life of radium and helping demonstrate the existence of isotopes. She was Vice President of the Norwegian Association for Women's Rights 1937–1939.
Steinar Stokke is a Norwegian businessperson and former civil servant, with prominent positions in the health sector.
Bjørn Kristoffer Erikstein is a Norwegian physician and civil servant, with prominent positions in the health sector.
Ingar Pettersen is a Norwegian consultant and former civil servant, with prominent positions in the health sector.
Olav Torgersen was a Norwegian pathologist.
Ragnhild Adelheid Lothe is a Norwegian microbiologist and cancer researcher.
The King Olav V's Prize for Cancer Research is a research award given annually by the Norwegian Cancer Society to a researcher who has distinguished himself through his scientific contributions to Norwegian cancer research. It was established in 1992.
Anne-Lise Børresen-Dale is a Norwegian biochemist. She is a senior scientist at Oslo University Hospital and Professor of molecular tumor biology at the University of Oslo. She received the 2002 Nordic Medical Prize. In 2015 she received the Fritjof Nansen medal and award for Outstanding Research from the Norwegian Academy of Science and Letters, and in 2017 she was appointed to Commander of the Royal Norwegian St. Olavs Order by the King of Norway.
